Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer

D. Skarlos, E. Samantas, P. Kosmidis, +12

Annals of Oncology

Radiation MedicineHealth SciencesRadiation TherapyMedicineCancer Treatment +6

Carboplatin Plus Paclitaxel in Unknown Primary Carcinoma: A Phase II Hellenic Cooperative Oncology Group Study

Evangelos Briasoulis, D. Bafaloukos, E. Samantas, +6

Journal of Clinical Oncology

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

C. Christodoulou, Dimitrios Bafaloukos, P. Kosmidis, +6

Annals of Oncology

Neuro-oncologyBrain MetastasesMedicineMetronomic TherapyPhase Ii Study +6

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Dimosthenis Skarlos, E. Samantas, Evangelos Briassoulis, +12

Annals of Oncology

Radiation MedicineHealth SciencesRadiation TherapyMedicineEarly Versus +8

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

George Pentheroudakis, George Fountzilas, Dimitrios Bafaloukos, +7

Breast Cancer Research and Treatment

Surgical OncologyMetastatic Breast CancerHepatologyBreast OncologyMedicine +10

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Aristotelis Bamias, Urania Dafni, Alexandra Karadimou, +17

Annals of Oncology

Surgical OncologyUrologyHe 16/03Genitourinary CancerMedicine +5

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

Dimitrios Pectasides, George Papaxoinis, Konstantine T. Kalogeras, +17

BMC Cancer

Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation

George Fountzilas, Mattheos Bobos, Anna Kalogera‐Fountzila, +11

Cancer Investigation

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

George Pentheroudakis, Konstantine T. Kalogeras, Ralph M. Wirtz, +13

Breast Cancer Research and Treatment

Breast OncologyProgesterone ReceptorMedicineHormonal ReceptorEstrogen Receptor +7

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Kyriaki Pliarchopoulou, Konstantine T. Kalogeras, Ralf Kronenwett, +13

Cancer Chemotherapy and Pharmacology

Breast OncologyOncologyBreast Cancer PatientsMedicinePathology +7